Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (471-480 of 662) with videos related to

Pageof 67
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label studyCatherine Cordonnier, Per Ljungman, Christine Juergens, et al.
Emergency Medicine Australasia : EMA|September 14, 2023
Management and outcomes with 5-year mortality of patients with mildly elevated high-sensitivity troponin T levels not meeting criteria for myocardial infarctionWeaam Alazrag, Hanan Idris, Yousef Me Saad, et al.
Heart, Lung & Circulation|March 5, 2013
Evaluation of a policy of selective drug-eluting stent implantation for patients at high risk of restenosisIbrahim M Shugman, Hanan Idris, Krishna Kishor Kadappu, et al.
Plos One|June 29, 2021
Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reportsMichael Bonert, Uzma Zafar, Raymond Maung, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2021
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancerBarbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, et al.
Vaccine|April 27, 2010
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in GermanyDorothee M Kieninger, Kathrin Kueper, Katrin Steul, et al.
Pediatric Blood & Cancer|September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective studyAnnemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
NPJ Vaccines|April 8, 2026
Noncanonical amino acids enable plug and play vaccine platform in the ALiCE cell free systemJorge Armero-Gimenez, Janis Schleusner, Ruud H P Wilbers, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2013
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancerCharles M Rudin, Julie R Brahmer, Rosalyn A Juergens, et al.
Pageof 67

Showing results (471-480 of 662) with videos related to

Sort By:
Pageof 67
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label studyCatherine Cordonnier, Per Ljungman, Christine Juergens, et al.
Emergency Medicine Australasia : EMA|September 14, 2023
Management and outcomes with 5-year mortality of patients with mildly elevated high-sensitivity troponin T levels not meeting criteria for myocardial infarctionWeaam Alazrag, Hanan Idris, Yousef Me Saad, et al.
Heart, Lung & Circulation|March 5, 2013
Evaluation of a policy of selective drug-eluting stent implantation for patients at high risk of restenosisIbrahim M Shugman, Hanan Idris, Krishna Kishor Kadappu, et al.
Plos One|June 29, 2021
Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reportsMichael Bonert, Uzma Zafar, Raymond Maung, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2021
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancerBarbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, et al.
Vaccine|April 27, 2010
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in GermanyDorothee M Kieninger, Kathrin Kueper, Katrin Steul, et al.
Pediatric Blood & Cancer|September 25, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective studyAnnemiek M van Maldegem, Charlotte Benson, Piotr Rutkowski, et al.
NPJ Vaccines|April 8, 2026
Noncanonical amino acids enable plug and play vaccine platform in the ALiCE cell free systemJorge Armero-Gimenez, Janis Schleusner, Ruud H P Wilbers, et al.
International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2013
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancerCharles M Rudin, Julie R Brahmer, Rosalyn A Juergens, et al.
Pageof 67